Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 PharmSci 360 Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
D
M1030-07-39
Days or Centuries? Predicting the Shelf-Life of ASDs
Favorite
M1430-09-50
De Novo Development and Validation of a Flow Cytometry Method for the Detection of Neutralizing Antibodies against Adeno-Associated Virus Serotype 5 (AAV5)
Favorite
M0930-02-10
Debulking of SARS-CoV-2 and Influenza Virus Strains by Plant Viral Trap Proteins in Chewing Gums to Decrease Infection and Transmission
Favorite
T1030-07-40
Delivering Smarter Medicines with On-Dose Microtaggants and Smartphone Technology
Favorite
T1030-05-27
Dendrimer Conjugated nSMase2 Inhibitor (D-DPTIP) as a Novel Treatment for Alzheimer’s Disease
Favorite
M1430-03-17
Design and Development of Folate Decorated Nanoemulsions as the New Pain Nanomedicines
Favorite
T1330-10-58
Design and Development of Protease-Activated Chemically Self-Assembled Nanorings (Pro-CSANs) for Cancer Immunotherapy
Favorite
M1530-07-38
Design and Development of Rifampicin Loaded PLGA Nanoparticles for the Prevention of Prosthetic Infections
Favorite
T1030-03-13
Design and Optimization of Ciprofloxacin Hydrochloride Biodegradable 3D Printed Ocular Inserts: Full Factorial Design In Vitro and Ex Vivo Evaluations
Favorite
M1330-01-03
Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design Approach
Favorite
T1330-03-16
Design of a Personalized Nasal Device (Matrix-Piston Device, MPD) for Nose-to-Brain Delivery: A 3D-Printing Application
Favorite
W1030-04-21
Design of Amorphous Solid Dispersions for the Synchronized Release of Two Drugs
Favorite
M1530-09-50
Design of Total VEGF Assay Provides Simple Data Interpretation of Anti-VEGF Therapeutic Study
Favorite
T1530-04-23
Determination of Binding Constants between Diflunisal and Trazodone and Several Excipients
Favorite
W1030-08-46
Determination of the Evacuation Time of a Newly Developed Chamber Setup for the Investigation of the Spatial Dust Distribution of Pharmaceutical Powders
Favorite
M0930-01-06
Determination of Time-Temperature-Transformation Curve for Sulfonyl Urea Analogues in the Presence of a Crystallization Inhibitor using Simultaneous XRD-DSC
Favorite
M1430-04-22
Determining Critical Parameters that Predict Physical Stability of Amorphous Solid Dispersions
Favorite
M1330-10-59
Determining the Efficacy and Toxicity Profile of Potential Oral Therapeutics Against SARS-CoV-2 in Mice
Favorite
T1530-06-31
Determining the Minimum Required Thickness of Enteric Coatings by Means of Optical Coherence Tomography
Favorite
T1330-04-19
Developability Assessment as an Early De-risking Tool for Biopharmaceuticals: Case Study with Fusion-Proteins
Favorite
T1130-05-26
Developing a Dual Prodrug for Triggered Antibiotic Activation
Favorite
T1230-01-01
Developing a Stable Model Formulation to be Used as a Platform Technology for BCS Class II and IV Hydrophobic Molecules with Log P >3 while Using an Aprotic Solvent System as a Solubilizer and Carrier
Favorite
M0930-07-39
Developing an In Vitro System to Emulate the In Vivo Subcutaneous Environment and Predict the Fate of Drugs in Subcutaneous Delivery: Assessment of Biologics
Favorite
T0930-07-39
Developing an In Vitro System to Emulate the In Vivo Subcutaneous Environment and Predict the Fate of Drugs in Subcutaneous Delivery: Assessment of Small Molecule Drugs
Favorite
T1430-04-22
Developing an Inhaled Nano-Emulsion for Repurposing an Herbal Drug for Non-small Cell Lung Cancer
Favorite
M1430-07-40
Developing Cyclodextrin-Complexed Edaravone – An Inhaled Repurposed Therapy for Idiopathic Pulmonary Fibrosis (IPF)
Favorite
M0930-04-24
Developing Efficient Bioequivalence Approaches for Generic Vaginal Drug Products
Favorite
M1130-03-18
Developing In Vitro Lipolysis Model for Real-Time Analysis of Drug Concentrations during Digestion of Lipid-Based Formulations
Favorite
T1030-01-03
Development and Characterization of Multi-layer Self-Nanoemulsifying Pellets Using Fluid Bed Coating Technique to Enhance the Dissolution and Stability of Ramipril
Favorite
M0930-03-13
Development and Characterization of Primaquine and Chloroquine Solid Dispersion Loaded Dissolving Microneedles for the Improved Treatment of Malaria
Favorite
W0930-04-23
Development and Evaluation of a Drug-in-Adhesive Transdermal Delivery System for Delivery of Olanzapine for Treatment of Schizophrenia and Bipolar Disorder
Favorite
W1130-03-14
Development and Evaluation of a Label Friendly Film Coating System Containing Naturally Derived Opacifier
Favorite
T1130-12-70
Development and Evaluation of Polyvinylpyrrolidone and Chitosan-Based Film Forming Gel containing Acyclovir
Favorite
M1130-12-70
Development and Evaluation of Transdermal Delivery System of Tranylcypromine for the Treatment of Depression
Favorite
T1130-03-15
Development and In Vitro Characterization of STAT6 siRNA Loaded PEGylated Gelatin Nanocarriers as an Anti-Asthmatic Therapy
Favorite
W0930-12-68
Development and In Vivo Testing of an Enteric Oral Dosage Form of an Amorphous Solid Dispersion in Beagle Dogs that Generates Amorphous Nanoparticles during Dissolution
Favorite
W0930-09-50
Development and Validation of a Blood Micro Sampling Methodology to Facilitate Conduct of Pharmacokinetic Studies in Pregnant and Postpartum Patients
Favorite
T0930-09-53
Development and Validation of a Human Soluble MICA Biomarker Assay for use in Clinical Studies
Favorite
M1230-06-31
Development and Validation of a Stability Indicating UPLC-DAD Method For The Simultaneous Determination of Praziquantel and Ivermectin In 57/0.18 mg Pharmaceutical Tablets and Dissolution Samples.
Favorite
M1130-09-51
Development and Validation of an LC-MS/MS Method for Determination of Difelikefalin in Human Plasma
Favorite
W0930-09-52
Development and Validation of Chiral HPLC Method for Quantification of L(-) and D(+) Epinephrine in Autoinjectors
Favorite
M1130-10-57
Development and Verification of Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Dapivirine Ring and Gel Formulation
Favorite
M1230-01-04
Development of 3D-Printed Gastro-Retentive Sustained Release Mini Device Using Ingestible Compounds
Favorite
M1230-09-50
Development of a Bridging ECL Method for the Detection of Anti-Drug Antibodies in Human Serum on an Automated System
Favorite
T1430-10-59
Development of a Broadly Active Influenza Intranasal Vaccine Adjuvanted with Self-Assembled Particles Comprised of Mastoparan-7 and CpG
Favorite
M1030-01-06
Development of a Child-Friendly Antibiotic Packed Multiparticulate Oral Sprinkle Formulation for Tuberculosis Pharmacotherapy
Favorite
T1130-05-27
Development of a Delayed Release Softgel Dosage Form
Favorite
W1130-12-70
Development of a Donepezil Dry Powder Formulation for Enhanced Nasal Mucosa Permeation
Favorite
T1530-12-71
Development of a Fixed Dose Combinations Using Double Melt Extrusion Technology
Favorite
M1430-09-53
Development of a Generic Assay Platform Using Human IgG Light Chain-Specific Antibody Reagents for Concentration Measurement of Antibody Therapeutic in Preclinical Studies
Favorite
T1130-04-23
Development of a Low-Dose Pilocarpine Ophthalmic Formulation that is Stable, Well-Tolerated and Bioavailable at a Near-Neutral pH for the Treatment of Presbyopia
Favorite
W1030-03-14
Development of a Low-Volume In Vitro Dissolution Method for Assessing Variability in Fine Particle Doses of Dry Powder Inhalers
Favorite
T1430-06-31
Development of a Lyophilized Single Vial Adjuvanted Sub-unit Vaccine for Bed Side Reconstitution
Favorite
T1430-10-55
Development of a Novel Tocotrienol Analogue, Tocoflexol, as a Powerful Radioprotective Agent
Favorite
T1130-09-52
Development of a Robust and Sensitive Microflow LC-MS/MS Workflow for the Analysis of Oligonucleotides
Favorite
M1330-07-42
Development of a Theranostic Agent for Potential Diagnosis and Treatment of High-Risk Neuroblastoma in Children
Favorite
T1230-03-18
Development of a UV Imaging Method for Characterization of Intra-Tumoral Injectables Using cAMP as Model Substance
Favorite
T1430-11-63
Development of Accelerated Transdermal Diffusion model for In Vitro Permeation Testing of Topical Pharmaceuticals
Favorite
T1030-12-69
Development of Amorphous Solid Dispersion of Aprepitant Using Sucrose Acetate iso butyrate for Dissolution and Bioavailability Enhancement
Favorite
M0930-02-08
Development of an Aqueous Formulation of Immulina and the Evaluation of Its Anticancer Effect against B16 Melanoma
Favorite
M1030-09-50
Development of an Automated and High Throughput UHPLC/MS Based Workflow for Cleaning Verification of Potent Compounds in the Pharmaceutical Manufacturing Environment
Favorite
M1530-09-53
Development of an Extractionless, Multiplexed Assay for the Direct Detection of miRNAs in Liver Tissue
Favorite
M1230-04-20
Development of an In Vitro Release Method for Mechlorethamine Hydrochloride Topical Gel
Favorite
W0930-07-39
Development of Biodegradable Injectable In Situ Forming Implants for Controlled Release of Cannabinoids: In Ovo Assessment
Favorite
W1130-03-15
Development of Bupivacaine Hydrochloride Mucoadhesive In Situ Forming Gels for Oral Mucositis
Favorite
T1330-06-31
Development of Cell-Based Bioassays for Measuring the Potency of Biological Drug Products
Favorite
W1130-03-16
Development of Enhanced the Physicochemical Properties, Solubility, and Oral Bioavailability of Rivaroxaban-Loaded Solid Self-nanoemulsifying Drug Delivery Systems
Favorite
M1430-07-37
Development of Inhalable Layer-by-Layer Assembled Particles for Small Cell Lung Cancer (SCLC) Treatment
Favorite
M1030-07-38
Development of Lipid Formulation for Oral Delivery of Proteins and Peptides with Poor Permeability
Favorite
W0930-07-37
Development of MMP2-Sensitive Carbon Nanotubes for Tumor-Targeted Drug Delivery
Favorite
M1430-12-69
Development of Multilayer 3D DLP Printed Tablet in One Step Using Automated Rotary Platform
Favorite
M1330-12-69
Development of Nicotine Dry Powder for Inhalation by Thin-Film Freezing
Favorite
M1130-05-29
Development of Novel Macropinocytosis Inducers to Enhance Cellular Uptake of Small and Large Molecules
Favorite
M1430-04-20
Development of Novel Topical Formulations of 5-fluorouracil
Favorite
M1030-09-53
Development of Rapid LC-MS-MS Method for Therapeutic Monitoring of Plazomicin in Human Plasma
Favorite
T0930-07-41
Development of Scalable and Inhaled Nintedanib-Loaded Polymeric Nanoparticles for Localized Therapy of Idiopathic Pulmonary Fibrosis
Favorite
T1430-01-01
Development of Sublingual Tablets Containing Promethazine Hydrochloride for Paediatric Applications
Favorite
T1430-12-67
Development of Topical Foam Formulation for Decontamination Post Exposure to Lewisite and Extended Antidote Delivery upon Reapplication
Favorite
T1030-07-39
Development, Characterization and Stability Studies of Amphotericin B and Nonadecanoic Acid loaded Nanostructured Lipid Carriers for Fungal Keratitis
Favorite
T1130-08-44
Dexamethasone Intravitreal Implants: Manufacture, Characterization, and Elucidation of Drug Release Mechanisms
Favorite
T1430-07-38
Different Pharmacokinetics and Local Inflammation between Injectable Aqueous Drug Suspension and Oil Suspension
Favorite
T0930-10-55
Differential Gene Expression of Human Brain Endothelial Cells Compared to Endothelial Cells Co-cultured with Pericytes
Favorite
M1230-01-05
Digital Light Processing (DLP) 3D Printed Tablets and Its Pharmacokinetic Evaluation in Rats
Favorite
M1530-06-33
Dimensional Conformity of Filaments in Hot-Melt Extrusion: Design of Experiment and Process Optimization
Favorite
T1230-09-51
Direct Monitoring of DNA Plasmid Concentration and the Extent of Plasmid-Liposome Complexation Using 2
nd
Derivative Fiber-Optic UV Spectroscopy
Favorite
M1530-07-42
Discovery of a Targeted Oral Prodrug for Prostate Cancer Therapy
Favorite
T1230-10-59
Discovery of Anti-LAG-3 Peptides for Cancer Immunotherapy
Favorite
M1530-10-59
Discovery of OJT009 as a Novel Inhibitor of Severe Acute Respiratory Syndrome Coronavirus 2
Favorite
T1230-05-28
Discovery of Peptides to Target Lung Epithelia from Cystic Fibrosis Patients
Favorite
W0930-11-62
Disposition and Metabolism of [<sup>14</sup>C]-Tirzepatide following Subcutaneous Administration in Healthy Male Participants
Favorite
T0930-07-38
Dissolution Bioequivalence Safe Space Assessment of Molnupiravir and NHC Using Physiologically Based Biopharmaceutics Modeling
Favorite
T1530-12-72
Dissolution Rate Increases for Morphine Sulfate Extended-Release Drug Product When Mixed with High pH Soft Food for Long Contact Times
Favorite
M0930-05-26
Distinguishing Tobacco-Derived Nicotine from Synthetic Nicotine in Commercial Nicotine Samples
Favorite
W0930-10-55
DNA-Based cGAS Agonists as a Novel Approach to cGAS-STING Activation for Cancer Immunotherapy
Favorite
M1330-10-55
Do We Emit Drugs through Our Skin?
Favorite
T1530-04-21
Dose Dependency Effect on the Skin Permeation of Polar and Non-Polar Compounds
Favorite
T1430-06-33
Downstream Processing of Itraconazole:HPMCAS Amorphous Solid Dispersion: From Hot-Melt Extrudate to Tablet Using a Quality by Design Approach
Favorite
T1030-03-18
Drug and Colloidal Characteristics Impact the Unstirred Water Layer Thickness
Favorite
M1130-10-58
Drug Repurposing: A Therapeutic Approach to Modulate Immune Microenvironment in Pancreatic Cancer
Favorite
M1530-03-15
Drug-Loaded Hydralese™ Poly(Glycerol Sebacate) Urethane Elastomers as Intra-vitreal Microdevices for Ocular Drug Delivery Applications
Favorite
M0930-04-21
Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous State and Solubility Enhancement in Solution
Favorite
M1330-04-24
Dual Immunization Against COVID-19 and Influenza Using Fast-Dissolving Buccal Films
Favorite
M0930-06-35
Dust Emissions of Surrogate Substances Resulting from Diffusive and Convective Transport for Containment Investigations with a Newly Developed Two-Chamber Setup
Favorite
M1430-05-25
Dynamic Monitoring of Cancer Cell Growth in Monolayer and 3D Spheroid Cultures by Fluorescence – Correlation with Volume, Cell Viability, and Cellular Protein Measurements
Favorite
M1230-04-19
Dysphagia Prevalence and Pollution
Favorite